Follow
Marc Feldmann
Marc Feldmann
Imperial College and Oxford
Verified email at kennedy.ox.ac.uk
Title
Cited by
Cited by
Year
Infliximab and methotrexate in the treatment of rheumatoid arthritis
PE Lipsky, DMFM van der Heijde, EW St. Clair, DE Furst, FC Breedveld, ...
New England Journal of Medicine 343 (22), 1594-1602, 2000
40742000
Role of cytokines in rheumatoid arthritis
M Feldmann, FM Brennan, RN Maini
Annual review of immunology 14 (1), 397-440, 1996
3942*1996
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase …
R Maini, EW St Clair, F Breedveld, D Furst, J Kalden, M Weisman, ...
The Lancet 354 (9194), 1932-1939, 1999
31081999
An inflammatory cytokine signature predicts COVID-19 severity and survival
DM Del Valle, S Kim-Schulze, HH Huang, ND Beckmann, S Nirenberg, ...
Nature medicine 26 (10), 1636-1643, 2020
23282020
Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis
MJ Elliott, RN Maini, M Feldmann, JR Kalden, C Antoni, JS Smolen, ...
The Lancet 344 (8930), 1105-1110, 1994
22191994
Therapeutic efficacy of multiple intravenous infusions of anti‐tumor necrosis factor α monoclonal antibody combined with low‐dose weekly methotrexate in rheumatoid arthritis
RN Maini, FC Breedveld, JR Kalden, JS Smolen, D Davis, JD MacFarlane, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 1998
21801998
Anti-TNFα therapy of rheumatoid arthritis: what have we learned?
M Feldmann, RN Maini
Annual review of immunology 19 (1), 163-196, 2001
17912001
Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
GF Bottazzo, T Hanafusa, R Pujol-Borrell, M Feldmann
The Lancet 322 (8359), 1115-1119, 1983
15601983
Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor α
MJ Elliott, RN Maini, M Feldmann, A Long‐Fox, P Charles, P Katsikis, ...
Arthritis & Rheumatism 36 (12), 1681-1690, 1993
15031993
IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses
T Krausgruber, K Blazek, T Smallie, S Alzabin, H Lockstone, N Sahgal, ...
Nature immunology 12 (3), 231-238, 2011
14372011
Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.
RO Williams, M Feldmann, RN Maini
Proceedings of the National Academy of Sciences 89 (20), 9784-9788, 1992
13591992
Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
FM Brennan, A Jackson, D Chantry, R Maini, M Feldmann
The Lancet 334 (8657), 244-247, 1989
13331989
Excessive production of interleukin 6/B cell stimulatory factor‐2 in rheumatoid arthritis
T Hirano, T Matsuda, M Turner, N Miyasaka, G Buchan, B Tang, K Sato, ...
European journal of immunology 18 (11), 1797-1802, 1988
10321988
Development of anti-TNF therapy for rheumatoid arthritis
M Feldmann
Nature Reviews Immunology 2 (5), 364-371, 2002
9242002
Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis
MJ Elliott, RN Maini, M Feldmann, A Long-Fox, P Charles, JA Bijl, ...
The Lancet 344 (8930), 1125-1127, 1994
9131994
Role of interleukin‐1β in postoperative cognitive dysfunction
M Cibelli, AR Fidalgo, N Terrando, D Ma, C Monaco, M Feldmann, ...
Annals of neurology 68 (3), 360-368, 2010
8732010
The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis
AM Malfait, R Gallily, PF Sumariwalla, AS Malik, E Andreakos, ...
Proceedings of the National Academy of Sciences 97 (17), 9561-9566, 2000
8282000
Localization of tumor necrosis factor α in synovial tissues and at the cartilage–pannus junction in patients with rheumatoid arthritis
CQ Chu, M Field, M Feldmann, RN Maini
Arthritis & Rheumatism: Official Journal of the American College of …, 1991
7981991
Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-α therapy in rheumatoid arthritis
P Charles, MJ Elliott, D Davis, A Potter, JR Kalden, C Antoni, ...
The Journal of Immunology 163 (3), 1521-1528, 1999
7761999
TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseases
M Feldmann, RN Maini
Nature medicine 9 (10), 1245-1250, 2003
7552003
The system can't perform the operation now. Try again later.
Articles 1–20